US Stock MarketDetailed Quotes

Spruce Biosciences (SPRB)

Watchlist
  • 54.370
  • +0.360+0.67%
Close Apr 24 15:59 ET
  • 53.250
  • -1.120-2.06%
Post 20:01 ET
146.92MMarket Cap-1.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spruce Biosciences (SPRB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
40.45%-33.33M
68.78%-6.46M
42.36%-5.32M
20.51%-8.83M
14.92%-12.73M
-68.19%-55.96M
-84.47%-20.68M
24.83%-9.22M
-657.25%-11.11M
-26.87%-14.96M
Net income from continuing operations
26.53%-38.97M
37.83%-14.65M
5.29%-8.21M
77.49%-2.07M
-20.78%-14.04M
-10.68%-53.04M
-136.77%-23.56M
29.81%-8.67M
28.41%-9.18M
9.12%-11.63M
Operating gains losses
174,900.00%3.5M
--4.02M
--102K
---461K
---158K
0.00%2K
--0
--0
----
----
Depreciation and amortization
-54.35%21K
-44.44%5K
-70.00%3K
-41.67%7K
-60.00%6K
-34.29%46K
-43.75%9K
-41.18%10K
-33.33%12K
-21.05%15K
Other non cash items
8.50%268K
7.81%69K
9.68%68K
8.20%66K
8.33%65K
7.39%247K
-89.83%64K
112.09%62K
-74.48%61K
148.00%60K
Change In working capital
91.55%-724K
30.25%2.41M
230.84%2.31M
-70.85%-6.3M
117.24%857K
-182.76%-8.57M
174.25%1.85M
-81.29%-1.76M
-126.76%-3.69M
-11,144.44%-4.97M
-Change in receivables
----
----
----
----
----
----
----
----
----
--0
-Change in prepaid assets
525.83%2.45M
157.45%841K
-36.26%719K
-56.97%395K
357.59%492K
114.83%391K
59.12%-1.46M
377.97%1.13M
1,940.00%918K
-128.77%-191K
-Change in payables and accrued expense
33.75%-2.85M
-62.75%1.37M
174.41%1.67M
-125.36%-6.61M
125.90%724K
-152.79%-4.31M
-9.33%3.66M
-215.32%-2.24M
-410.15%-2.93M
-327.42%-2.8M
-Change in other current assets
--0
--0
--0
--0
--0
414.58%494K
3,021.43%409K
134.29%12K
91.67%-1K
-52.87%74K
-Change in other current liabilities
-33.76%-317K
414.06%201K
-33.33%-80K
-36.21%-79K
-552.73%-359K
-34.66%-237K
-33.33%-64K
-30.43%-60K
-41.46%-58K
-34.15%-55K
-Change in other working capital
----
----
----
----
----
-200.00%-4.91M
75.86%-697K
80.44%-601K
25.64%-1.61M
-115.37%-2M
Cash from discontinued investing activities
Operating cash flow
40.45%-33.33M
68.78%-6.46M
42.36%-5.32M
20.51%-8.83M
14.92%-12.73M
-68.19%-55.96M
-84.47%-20.68M
24.83%-9.22M
-657.25%-11.11M
-26.87%-14.96M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
Net PPE purchase and sale
----
----
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
2,780.70%43.48M
7,251.04%44.69M
0.74%-402K
-9.59%-400K
-81.06%-411K
-103.30%-1.62M
-13.22%-625K
0.00%-405K
15.51%-365K
-100.45%-227K
Net issuance payments of debt
-26.82%-2.06M
-107.14%-841K
0.00%-405K
0.00%-406K
0.00%-405K
0.00%-1.62M
0.00%-406K
0.00%-405K
0.00%-406K
0.00%-405K
Net common stock issuance
--50M
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-71.54%70K
378.57%67K
--3K
--0
--0
38.20%246K
-80.28%14K
--0
-51.40%52K
--180K
Net other financing activities
-1,742.28%-4.53M
----
----
----
-200.00%-6K
91.89%-246K
-7.37%-233K
--0
91.73%-11K
99.93%-2K
Cash from discontinued financing activities
Financing cash flow
2,780.70%43.48M
7,251.04%44.69M
0.74%-402K
-9.59%-400K
-81.06%-411K
-103.30%-1.62M
-13.22%-625K
0.00%-405K
15.51%-365K
-100.45%-227K
Net cash flow
Beginning cash position
-59.75%38.79M
-82.19%10.7M
-76.45%16.42M
-68.41%25.65M
-59.75%38.79M
289.67%96.37M
-39.20%60.09M
-28.51%69.72M
9.78%81.19M
289.67%96.37M
Current changes in cash
117.63%10.15M
279.50%38.24M
40.61%-5.72M
19.55%-9.23M
13.48%-13.14M
-180.38%-57.59M
-765.58%-21.3M
-829.95%-9.63M
-148.69%-11.47M
-130.85%-15.19M
End cash Position
26.18%48.94M
26.18%48.94M
-82.19%10.7M
-76.45%16.42M
-68.41%25.65M
-59.75%38.79M
-59.75%38.79M
-39.20%60.09M
-28.51%69.72M
9.78%81.19M
Free cash flow
40.45%-33.33M
68.78%-6.46M
42.36%-5.32M
20.51%-8.83M
14.92%-12.73M
-68.15%-55.96M
-84.47%-20.68M
24.87%-9.22M
-657.25%-11.11M
-26.87%-14.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 40.45%-33.33M68.78%-6.46M42.36%-5.32M20.51%-8.83M14.92%-12.73M-68.19%-55.96M-84.47%-20.68M24.83%-9.22M-657.25%-11.11M-26.87%-14.96M
Net income from continuing operations 26.53%-38.97M37.83%-14.65M5.29%-8.21M77.49%-2.07M-20.78%-14.04M-10.68%-53.04M-136.77%-23.56M29.81%-8.67M28.41%-9.18M9.12%-11.63M
Operating gains losses 174,900.00%3.5M--4.02M--102K---461K---158K0.00%2K--0--0--------
Depreciation and amortization -54.35%21K-44.44%5K-70.00%3K-41.67%7K-60.00%6K-34.29%46K-43.75%9K-41.18%10K-33.33%12K-21.05%15K
Other non cash items 8.50%268K7.81%69K9.68%68K8.20%66K8.33%65K7.39%247K-89.83%64K112.09%62K-74.48%61K148.00%60K
Change In working capital 91.55%-724K30.25%2.41M230.84%2.31M-70.85%-6.3M117.24%857K-182.76%-8.57M174.25%1.85M-81.29%-1.76M-126.76%-3.69M-11,144.44%-4.97M
-Change in receivables --------------------------------------0
-Change in prepaid assets 525.83%2.45M157.45%841K-36.26%719K-56.97%395K357.59%492K114.83%391K59.12%-1.46M377.97%1.13M1,940.00%918K-128.77%-191K
-Change in payables and accrued expense 33.75%-2.85M-62.75%1.37M174.41%1.67M-125.36%-6.61M125.90%724K-152.79%-4.31M-9.33%3.66M-215.32%-2.24M-410.15%-2.93M-327.42%-2.8M
-Change in other current assets --0--0--0--0--0414.58%494K3,021.43%409K134.29%12K91.67%-1K-52.87%74K
-Change in other current liabilities -33.76%-317K414.06%201K-33.33%-80K-36.21%-79K-552.73%-359K-34.66%-237K-33.33%-64K-30.43%-60K-41.46%-58K-34.15%-55K
-Change in other working capital ---------------------200.00%-4.91M75.86%-697K80.44%-601K25.64%-1.61M-115.37%-2M
Cash from discontinued investing activities
Operating cash flow 40.45%-33.33M68.78%-6.46M42.36%-5.32M20.51%-8.83M14.92%-12.73M-68.19%-55.96M-84.47%-20.68M24.83%-9.22M-657.25%-11.11M-26.87%-14.96M
Investing cash flow
Cash flow from continuing investing activities 00000
Net PPE purchase and sale ----------------------0--0------------
Net investment purchase and sale ----------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow ----------------------0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 2,780.70%43.48M7,251.04%44.69M0.74%-402K-9.59%-400K-81.06%-411K-103.30%-1.62M-13.22%-625K0.00%-405K15.51%-365K-100.45%-227K
Net issuance payments of debt -26.82%-2.06M-107.14%-841K0.00%-405K0.00%-406K0.00%-405K0.00%-1.62M0.00%-406K0.00%-405K0.00%-406K0.00%-405K
Net common stock issuance --50M------------------0--0--0--0--0
Proceeds from stock option exercised by employees -71.54%70K378.57%67K--3K--0--038.20%246K-80.28%14K--0-51.40%52K--180K
Net other financing activities -1,742.28%-4.53M-------------200.00%-6K91.89%-246K-7.37%-233K--091.73%-11K99.93%-2K
Cash from discontinued financing activities
Financing cash flow 2,780.70%43.48M7,251.04%44.69M0.74%-402K-9.59%-400K-81.06%-411K-103.30%-1.62M-13.22%-625K0.00%-405K15.51%-365K-100.45%-227K
Net cash flow
Beginning cash position -59.75%38.79M-82.19%10.7M-76.45%16.42M-68.41%25.65M-59.75%38.79M289.67%96.37M-39.20%60.09M-28.51%69.72M9.78%81.19M289.67%96.37M
Current changes in cash 117.63%10.15M279.50%38.24M40.61%-5.72M19.55%-9.23M13.48%-13.14M-180.38%-57.59M-765.58%-21.3M-829.95%-9.63M-148.69%-11.47M-130.85%-15.19M
End cash Position 26.18%48.94M26.18%48.94M-82.19%10.7M-76.45%16.42M-68.41%25.65M-59.75%38.79M-59.75%38.79M-39.20%60.09M-28.51%69.72M9.78%81.19M
Free cash flow 40.45%-33.33M68.78%-6.46M42.36%-5.32M20.51%-8.83M14.92%-12.73M-68.15%-55.96M-84.47%-20.68M24.87%-9.22M-657.25%-11.11M-26.87%-14.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -